New meta-analysis of treatment trials of hypertension: Improving the estimate of therapeutic benefit

Journal of Human Hypertension

Volumn 10, Issue 1, 1996, Pages 1-8

  Gueyffier, F ^a,b   Froment, A ^a   Gouton, M ^a  

^a Unité 60   (France)

^b INSTITUT DE RECHERCHES INTERNATIONALES SERVIER   (France)

Author keywords

Meta analysis; Randomised controlled trials; Subgroups; Treatment evaluation; Withdrawal

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ANTIHYPERTENSIVE THERAPY; ARTICLE; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CONTROLLED CLINICAL TRIAL; HUMAN; HYPERTENSION; INCIDENCE; ISCHEMIC HEART DISEASE; META ANALYSIS; MORBIDITY; MORTALITY; RANDOMIZED CONTROLLED TRIAL; STROKE; TREATMENT OUTCOME;

ADULT; AGED; ANTIHYPERTENSIVE AGENTS; BIAS (EPIDEMIOLOGY); BLOOD PRESSURE; CARDIOVASCULAR DISEASES; CEREBROVASCULAR DISORDERS; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE);

EID: 0030056841     PISSN: 09509240     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Cutler JA, Furberg CD. Drug treatment trials in hypertension: a review. Prevent Med 1985; 14: 499-518.
2. MacMahon SW et al. The effects of drug treatment for hypertension on morbidity and mortality from cardiovascular disease: a review of randomised controlled trials. Prog Cardiovas Dis 1986; 29 (suppl. I): 99-118.
3. Boissel JP, Moleur P. Problems with intervention trials in hypertension. Am Heart J 1987; 114: 1018-1029.
4. Rose G. Review of primary prevention trials. Am Heart J 1987; 114: 1013-1017.
5. Wilkstrand J. New concepts in the treatment of elderly hypertensive patients. Am Heart J 1988; 116: 296-301.
6. Staessen J et al. Mortality in various intervention trials in elderly hypertensive patients: a review. Eur Heart J 1988; 9: 215-222.
7. Hebert PR et al. The community-based randomised trials of pharmacologic treatment of mild-to-moderate hypertension. Am J Epidemiol 1988; 127: 581-590.
8. Report from the British Hypertension Society Working Party. Treating mild hypertension: agreement from the large trials. Br Med J 1989; 298: 694-698.
9. MacMahon SW et al. Blood pressure, stroke and coronary heart disase. Part 1. Lancet 1990; 335: 765-774.
10. Collins R et al. Blood pressure, stroke and coronary heart disease. Part 2. Lancet 1990; 335: 827-838.
11. Moser M, Hebert P, Hennekens C. An overview of the meta-analyses of the hypertension treatment trials. Arch Intern Med 1991; 151: 1277-1279.
12. Beard K et al. Management of elderly patients with sustained hypertension. Br Med J 1992; 304: 412-416.
13. Hansson L. Treatment of hypertension in the elderly. J Hypertens 1993; 11 (suppl. 4): S25-S27.
14. Thijs L et al. A meta-analysis of outcome trials in elderly hypertensives. J Hypertens 1992; 10: 1103-1109.
15. Wolff FW, Lindeman RD. Effects of treatment in hypertension: results of a controlled study. J Chron Dis 1966; 19: 227-240.
16. Veterans Administration Co-operative Study Group on Antihypertensive Agents. Effects of treatment on morbidity in hypertension: results in patients with diastolic blood pressures averaging 115 through 129 mm Hg. JAMA 1967; 202: 1028-1034.
17. Carter AB. Hypotensive therapy in stroke survivors. Lancet 1970; 1: 485-489.
18. Barraclough M, Weddel JM. Control of moderately raised blood pressure: report of a co-operative randomised controlled trial. Br Med J 1973; 3: 434-436.
19. Hypertension Stroke Co-operative Study Group. Effect of antihypertensive treatment on stroke recurrence. JAMA 1974; 229: 409-418.
20. McFate Smith W for the US Public Health Service Hospitals Co-operative Study Group. Treatment of mild hypertension: results of a ten year intervention trial. Circ Res 1977; 40 (suppl. I): 98-105.
21. Perry HM et al. Evaluation of drug treatment in mild hypertension: VA-NHLBI feasibility trial. Ann N Y Acad Sci 1978; 304: 267-288.
22. Helgeland A. Treatment of mild hypertension: a five year controlled drug trial: the Oslo Study. Am J Med 1980; 69: 725-732.
23. Management Committee. The Australian therapeutic trial in mild hypertension. Lancet 1980; 1: 1261-1267.
24. Sprackling ME et al. Blood pressure reduction in the elderly: a randomised controlled trial of methyldopa. Br Med J 1981; 283: 1151-1153.
25. Medical Research Council Working Party. MRC Trial of treatment of mild hypertension: principal results. Br Med J 1985; 291: 97-104.
26. Coope J, Warrender TS. Randomised trial of treatment of hypertension in elderly patients in primary care. Br Med J 1986; 293: 1145-1151.
27. Amery A et al. Influence of antihypertensive drug treatment on morbidity and mortality in patients over the age of 60 years. EWPHE results: subgroup analysis based on entry stratification. J Hypertens 1986; 4 (suppl. 6): S642-S647.
28. Mitchell Perry H Jr et al. Morbidity and mortality in the Systolic Hypertension in the Elderly Program Pilot Study. Stroke 1989; 20: 4-13.
29. SHEP Co-operative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension: final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA 1991; 265: 3255-3264.
30. Dalhöf B et al. Morbidity and mortality in the Swedish Trial in Old Patients with Hypertension (STOP-Hypertension). Lancet 1991; 338: 1281-1285.
31. Medical Research Council Working Party. Medical Research Council trial of treatment of hypertension in older adults: principal results. Br Med J 1992; 304: 405-412.
32. Gueyffier F et al. Why must we perform meta-analyses on individual patient data? The INDANA Project: an example in hypertension treatment. Controlled Clin Trials, 1994; 15: 50S.
33. Yusuf S et al. Beta-blockade during and after myocardial infarction: an overview of the randomised trials. Prog Cardiovasc Dis 1985; 27: 335-371.
34. Dersimonian R, Laird N. Meta-analysis in clinical trials. Controlled Clin Trials 1986; 7: 177-188.
35. Hauck WW, Anderson S, Leahy FJ III. Finite sample properties of some old and some new estimators of a common odds ratio from multiple 2 X 2 tables. J Am Stat Assoc 1982; 77: 145-152.
36. Hypertension Detection and Follow-up Program Cooperative Group. Five-year findings of the Hypertension Detection and Follow-up Program. I: Reduction in mortality of persons with high blood pressure, including mild hypertension. JAMA 1979; 242: 2562-2571.
37. Veterans Administration Co-operative Study Group on Antihypertensive Agents. Effects of treatment on morbidity in hypertension: results in patients with diastolic blood pressure averaging 90 through 114 mm Hg. JAMA 1970; 213: 1143-1152.
38. Ekbom T et al. The stroke preventive effect in elderly hypertensives cannot fully be explained by the reduction in office blood pressure: insights from the Swedish Trial in Old Patients with Hypertension (STOP-Hypertension). Blood Pressure 1992; 1: 168-172.